Semaglutide is generic for both Wegovy and Ozempic. Tirzepatide is the compounded form of Mounjaro. It is a human based glucagon-like peptide-1 and 2 (GLP1 and GLP2) receptor agonist prescribed as an adjunct to a reduced calorie diet and increased physical activity for chronic weight management in adult patients with a BMI that is considered outside a healthy range. It works by increasing the amount of insulin produced by the pancreas and decreasing the amount of glucagon produced by the liver. This combination results in reduced hunger, leading to weight loss.

​

We have a monthly program with no long term obligation. AA consultation is required to start the program, and all details will be discussed there.

​

It is contraindicated in patients with previous/chronic pancreatitis, history of medullary thyroid cancer, pregnant/breastfeeding, kidney disease, diabetic retinopathy, disease of the gallbladder, and/or multiple endocrine neoplasia syndrome type 2.